© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | GI IBD IA QUAN DETER ADL LVL | Medium Descr | GI IBD IA QUAN DETER ADL LEVELS VENOUS SERUM | Long Descr | Gastroenterology (irritable bowel disease [IBD]), immunoassay for quantitative determination of adalimumab (ADL) levels in venous serum in patients undergoing adalimumab therapy, results reported as a numerical value as micrograms per milliliter (µg/mL) | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2025-01-01 | Added | First appearance in codebook. |
| 2024-10-01 | Added | Code added |
Get instant expert-level medical coding assistance.